Amount : | 5 mg |
Purification : | ≥98% |
Content : | Boceprevir is supplied as a crystalline solid. |
Storage condition : | Store at -20°C, product is stable for at least two years. |
Alternative Name : | SCH 503034, Victrelis, |
Molecular Formula:C27H45N5O5,
Molecular Weight:519.7
Boceprevir is a protease inhibitor that covalently, yet reversibly, binds (Ki = 14 nM) to the catalytic site (Ser139) of hepatitis C virus (HCV) nonstructural protein 3/4A (NS3/4A), a serine protease that is essential for viral replication.It was shown to inhibit the NS3/4A protease in an in vitro HCV replicon system with an EC50 value of 200 nM.1 Boceprevir can inhibit the activity of recombinant HCV genotype 1a and 1b NS3/4A protease enzymes in vitro with Ki values of 14 nM for each subtype.2 It has been evaluated in phase III clinical studies in combination with the current standard of care for treatment of HCV.
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
There are currently no product reviews Write a review on this product! |
Abeomics Inc.致力于帮助科学家摆脱常规的动手实验室工作,从而帮助他们开展更多的创造性研究。我们通过提供定制和合同实验室服务来做到这一点,以缩短您的研发时间,并使您更快地专注于后续步骤。Abeomics由一组经验丰富的科学家组成,他们还建立了成功的全球业务,其中包括世界一流的生命科学试剂和合同实验室服务提供商IMGENEX Inc.,以及用于系统生物学和临床医学的复杂的交互式Web数据库Protein Lounge。生物信息学。